Panbela Therapeutics (PBLA) Institutional Ownership → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free PBLA Stock Alerts $0.38 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Panbela Therapeutics (NASDAQ:PBLA)CurrentInstitutional OwnershipPercentage4.37%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$132.22MNumber ofInstitutional Sellers(last 12 months)0 Get PBLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Panbela Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PBLA Institutional Buying and Selling by Quarter Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Panbela Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2023Anson Funds Management LP163,024$72K0.0%N/A0.971% 5/16/2023Altium Capital Management LP335,324$148K0.1%N/A1.998% 11/14/2022Armistice Capital LLC2,176,809$588K0.0%N/A5.324% 11/2/2022Clear Street LLC110,500$30K0.0%N/A0.532% 4/7/2022Fieldpoint Private Securities LLC62,621$132K0.0%-33.7%0.466% 2/14/2022Murchinson Ltd.136,753$238K0.0%-8.8%1.018% 1/24/2022Fieldpoint Private Securities LLC94,521$164K0.0%-31.8%0.704% 11/12/2021Fieldpoint Private Securities LLC138,660$301K0.1%-5.4%1.033% 11/9/2021BlackRock Inc.29,359$64K0.0%+22.2%0.219% 8/16/2021 Warberg Asset Management LLC11,567$33K0.0%N/A0.086% 8/13/2021Murchinson Ltd.150,000$425K0.2%N/A1.117% 8/13/2021Vanguard Group Inc.217,198$615K0.0%+941.8%1.618% 8/12/2021Fieldpoint Private Securities LLC146,500$359K0.1%-20.4%1.091% 8/11/2021CVI Holdings LLC41,667$118K0.0%N/A0.310% 8/6/2021Buckingham Strategic Wealth LLC24,927$71K0.0%N/A0.186% 5/19/2021Squarepoint Ops LLC15,538$61K0.0%N/A0.154% 5/18/2021Verition Fund Management LLC20,000$79K0.0%-67.0%0.198% 5/17/2021Ikarian Capital LLC345,013$1.36M0.0%N/A3.420% 4/23/2021Fieldpoint Private Securities LLC184,000$727K0.2%N/A1.824% 2/18/2021Verition Fund Management LLC60,606$216K0.0%N/A0.628% 2/17/2021Worth Venture Partners LLC21,794$78K0.1%N/A0.226% 2/13/2021 Essex Investment Management Co. LLC63,079$225K0.0%N/A0.654% 2/1/2021 Brand Asset Management Group Inc.57,144$203K0.1%N/A0.592% (Data available from 1/1/2016 forward) PBLA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBLA shares? During the previous two years, the following institutional investors and hedge funds held shares of Panbela Therapeutics shares: Armistice Capital LLC ($588K), Altium Capital Management LP ($148K), and Anson Funds Management LP ($72K), Clear Street LLC ($30K).Learn more on PBLA's institutional investors. What percentage of Panbela Therapeutics stock is owned by institutional investors? 4.37% of Panbela Therapeutics stock is owned by institutional investors. Learn more on PBLA's institutional investor holdings. Which institutional investors have been buying Panbela Therapeutics stock? The following institutional investors have purchased Panbela Therapeutics stock in the last 24 months: Armistice Capital LLC ($2.18M), Altium Capital Management LP ($335.32K), Anson Funds Management LP ($163.02K), and Clear Street LLC ($110.50K). How much institutional buying is happening at Panbela Therapeutics? Institutional investors have bought a total of 2,785,657 shares in the last 24 months. This purchase volume represents approximately $14.97B in transactions. Related Companies: Lucy Scientific Discovery Institutional Ownership NeuBase Therapeutics Institutional Ownership InMed Pharmaceuticals Institutional Ownership Galmed Pharmaceuticals Institutional Ownership 180 Life Sciences Institutional Ownership PainReform Institutional Ownership Qualigen Therapeutics Institutional Ownership Clearmind Medicine Institutional Ownership Notable Labs Institutional Ownership Evelo Biosciences Institutional Ownership This page (NASDAQ:PBLA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
